PDF Cover

Incentive Spirometer Market

Incentive Spirometer Market

The market for Incentive Spirometer was estimated at $480 million in 2023; it is anticipated to increase to $997 million by 2030, with projections indicating growth to around $1.68 billion by 2035.

Report ID:DS1801005
Author:Debadatta Patel - Senior Consultant
Published Date:November 2024
Datatree
Life Science
Medical Device
Incentive Spirometer
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Incentive Spirometer Market Outlook

Revenue, 2023

$480M

Forecast, 2033

$1.36B

CAGR, 2023 - 2033

11%
The Incentive Spirometer industry revenue is expected to be around $591.4 million in 2024 and expected to showcase growth with 11% CAGR between 2025 and 2034.

An incentive spirometer, a medical device designed to encourage patients to take deep breaths, is crucial in postoperative care, pulmonary rehabilitation, and chronic respiratory condition management. In 2023, the incentive spirometer market was valued at approximately USD 480 million, with projections to reach USD 997 million by 2030 and potentially USD 1.68 billion by 2035, growing at a CAGR of 11%. This growth is fueled by increasing incidences of respiratory conditions and the rising adoption of home care medical devices.

The device’s ease of use and effectiveness in preventing postoperative lung complications make it indispensable in both hospital and home care settings. With an aging population and growing awareness of respiratory health, incentive spirometers are becoming essential tools in healthcare systems worldwide

Incentive Spirometer market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2023-2033

Market Key Insights

  • The Incentive Spirometer market is projected to grow from $480.0 million in 2023 to $1.36 billion in 2033. This represents a CAGR of 11%, reflecting rising demand across Postoperative Recovery, Pulmonary Rehabilitation and Chronic Respiratory Conditions.
  • Teleflex, Smiths Medical, Cardinal Health are among the leading players in this market, shaping its competitive landscape.
  • U.S. and Germany are the top markets within the Incentive Spirometer market and are expected to observe the growth CAGR of 8.0% to 11.6% between 2023 and 2030.
  • Emerging markets including India, Brazil and Mexico are expected to observe highest growth with CAGR ranging between 10.6% to 13.8%.
  • Transition like Shift Toward Digital Respiratory Health Solutions is expected to add $116.8 million to the Incentive Spirometer market growth by 2030
  • The Incentive Spirometer market is set to add $883 million between 2023 and 2033, with manufacturer targeting Chronic Respiratory Conditions & Pulmonary Rehabilitation Application projected to gain a larger market share.
  • With Increasing prevalence of respiratory diseases, and Growth in postoperative care demand, Incentive Spirometer market to expand 184% between 2023 and 2033.
incentive spirometer market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Incentive Spirometer

Emerging markets with growing healthcare infrastructure create new demand for incentive spirometers, especially in hospitals

Growth Opportunities in North America and Asia-Pacific

North America Outlook

North America leads the incentive spirometer market due to high healthcare spending and rising awareness of respiratory health. Companies like Teleflex and Cardinal Health are prominent in this region

Asia-Pacific Outlook

Asia-Pacific, particularly China and India, shows growing demand for incentive spirometers due to rising respiratory conditions and expanding healthcare infrastructure. Key players in this region include Smiths Medical and Drive Medical

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Respiratory Diseases, and Rising Adoption in Home Care Settings

Rising cases of chronic respiratory diseases, such as COPD and asthma, drive demand for incentive spirometers in respiratory therapy With growing awareness of respiratory health, more patients are also using incentive spirometers at home for ongoing pulmonary care and recovery
The device’s effectiveness in preventing postoperative lung complications fuels its use in hospitals and home care, especially as surgeries increase
02

Restraint: High Device Costs for Low-Income Regions, and High Device Costs for Low-Income Regions

The price of incentive spirometers limits accessibility in low-income regions, impacting market expansion
The price of incentive spirometers limits accessibility in low-income regions, impacting market expansion
03

Opportunity: Increased Demand in Pulmonary Rehabilitation and Integration with Digital Health Platforms

As pulmonary rehabilitation programs expand, incentive spirometers play a growing role in supporting respiratory health and recovery
Development of digital incentive spirometers with app connectivity provides real-time feedback, supporting patient engagement and compliance
04

Challenge: Competition from Alternative Respiratory Devices

Alternative respiratory therapy devices offer similar benefits, adding competitive pressure for incentive spirometers

Supply Chain Landscape

1
Raw Material Supplier

BASF

Eastman

2
Device Manufacturer

Teleflex

Smiths Medical

3
Distributor

McKesson

Cardinal Health

4
End-User

Hospitals

Clinics

Home care

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Incentive Spirometer in Postoperative Recovery, Pulmonary Rehabilitation & Chronic Respiratory Conditions

Postoperative Recovery

Incentive spirometers help prevent atelectasis by encouraging patients to take deep breaths post-surgery, improving lung expansion and oxygenation. Key providers include Teleflex and Smiths Medical

Chronic Respiratory Conditions

For patients with conditions like COPD, incentive spirometers improve lung function and reduce respiratory complications. Companies like Cardinal Health and Vyaire Medical specialize in these devices for chronic care

Pulmonary Rehabilitation

In rehabilitation, incentive spirometers aid patients in strengthening their respiratory muscles and enhancing breathing capacity, supporting overall recovery. Leading providers include Medline and Drive Medical

Recent Developments

September 2024

Teleflex launched a digital incentive spirometer with app connectivity for real-time patient feedback

July 2024

Smiths Medical introduced an advanced incentive spirometer for improved postoperative care and patient comfort

April 2024

Cardinal Health expanded its distribution network to increase accessibility of incentive spirometers in emerging markets

Recent advancements in incentive spirometers highlight a shift toward digital integration and improved patient comfort. Teleflex’s digital spirometer targets connected healthcare, Smiths Medical focuses on postoperative care, and Cardinal Health expands global reach

Impact of Industry Transitions on the Incentive Spirometer Market

As a core segment of the Medical Device industry, the Incentive Spirometer market develops in line with broader industry shifts. Over recent years, transitions such as Shift Toward Digital Respiratory Health Solutions and Advancements in Pulmonary Rehabilitation Devices have redefined priorities across the Medical Device sector, influencing how the Incentive Spirometer market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift Toward Digital Respiratory Health Solutions

The integration of digital technology in respiratory devices enhances monitoring and patient engagement, supporting health management This industry transition is expected to add $116.8 million in the industry revenue between 2023 and 2030.
02

Advancements in Pulmonary Rehabilitation Devices

New incentive spirometer models tailored for pulmonary rehabilitation aid patients with tailored breathing exercises and support recovery

Related Reports

Loading related reports...